Reply to: "Protection against acetaminophen-induced liver injury with MG53: Muscle-liver axis and necroptosis"

J Hepatol. 2022 Aug;77(2):562-563. doi: 10.1016/j.jhep.2022.04.024. Epub 2022 May 5.

Authors

Sylvester M Black¹, Ziyue Zhang², Yu Han¹, Chunyu Zeng³, Jianjie Ma⁴

Affiliations

¹ Department of Surgery, The Ohio State University, Columbus, OH 43210, USA.
² Department of Cardiology, Daping Hospital, Third Military Medical University, Chongqing, China.
³ Department of Cardiology, Daping Hospital, Third Military Medical University, Chongqing, China. Electronic address: chunyuzeng01@163.com.
⁴ Department of Surgery, The Ohio State University, Columbus, OH 43210, USA. Electronic address: Jianjie.Ma@osumc.edu.

PMID: 35526783
DOI: 10.1016/j.jhep.2022.04.024

No abstract available

Publication types

Letter
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Acetaminophen / adverse effects
Chemical and Drug Induced Liver Injury* / etiology
Chemical and Drug Induced Liver Injury* / prevention & control
Chemical and Drug Induced Liver Injury, Chronic*
Humans
Liver
Muscles
Necroptosis

Substances

Acetaminophen

Grants and funding

R01 DK123475/DK/NIDDK NIH HHS/United States